Stefanik Co-Leads Amendment to Promote Medical Breakthroughs in Fight against Alzheimer’s

October 17, 2019
Press Release

Washington, D.C. – Congresswoman Elise Stefanik spoke in the Education and Labor Committee Markup of H.R. 3 today and offered an amendment to promote medical breakthroughs in the fight against Alzheimer’s by excluding drugs used to treat or cure the disease from the list of drugs the HHS secretary can select for government price controls.

“With one in four Americans struggling to afford their medications, it is incumbent on us to push for bipartisan solutions to lower the costs of prescription drugs for patients and families,” said Congresswoman Stefanik. “H.R. 3 is a radical proposal that threatens Americans’ access to life-saving medication. Let’s be clear: government price controls, take-it-or-leave-it offers dressed up as negotiations, and the threat of a 95% sales tax is a tax on innovation and a tax on life-saving cures. In contrast, my amendment ensures ongoing research to end Alzheimer’s disease for patients and families will not be endangered or stifled by the Democrats’ partisan legislation. Preserving access to life-saving innovation and medical breakthroughs is critical in our fight against Alzheimer’s and so many other diseases. I was proud to offer this amendment today in honor of each individual facing Alzheimer’s in my district, and am hopeful Congress can return to working together to deliver real solutions for the American people.”

Watch Congresswoman Stefanik’s full remarks here and below.

Issues: